Literature DB >> 22968768

Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease.

Leo H Wang1, Robert C Bucelli, Erica Patrick, Dhanashree Rajderkar, Enrique Alvarez Iii, Miranda M Lim, Gabriela Debruin, Victoria Sharma, Sonika Dahiya, Robert E Schmidt, Tammie S Benzinger, Beth A Ward, Beau M Ances.   

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD) is a rapidly progressive dementia (RPD) that can be difficult to identify antemortem, with definitive diagnosis requiring tissue confirmation. We describe the clinical, magnetic resonance imaging (MRI), cerebrospinal fluid (CSF), and electroencephalogram (EEG) measures of a small cohort of 30 patients evaluated for RPD. Clinical and diagnostic measures were cross-sectionally obtained from 17 sCJD patients (15 definite, two probable), 13 non-prion rapidly progressive dementia patients (npRPD), and 18 unimpaired controls. In a subset of patients (nine sCJD and nine npRPD) diffusion tensor imaging (DTI) measures [fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD)] were also obtained for the caudate, corpus callosum, posterior limb of the internal capsule, pulvinar, precuneus, and frontal lobe. Differences among groups were assessed by an analysis of variance. Compared to npRPD individuals, sCJD patients had cerebellar dysfunction, significantly higher CSF tau, "positive" CSF 14-3-3, and hyperintensities on diffusion-weighted imaging (DWI) that met previously established imaging criteria for sCJD. EEG changes were similar for the two groups. In addition, sCJD patients had significant decreases in DTI measures (MD, AD, RD but not FA) within the caudate and pulvinar compared to either npRPD patients or unimpaired controls. Our results confirm that CSF abnormalities and MRI (especially DWI) can assist in distinguishing sCJD patients from npRPD patients. Future longitudinal studies using multiple measures (including CSF and MRI) are needed for evaluating pathological changes seen in sCJD patients.

Entities:  

Mesh:

Year:  2012        PMID: 22968768      PMCID: PMC3651672          DOI: 10.1007/s00415-012-6664-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease.

Authors:  Claire E Sexton; Ukwuori G Kalu; Nicola Filippini; Clare E Mackay; Klaus P Ebmeier
Journal:  Neurobiol Aging       Date:  2010-07-08       Impact factor: 4.673

2.  Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease.

Authors:  Michael D Geschwind; Christopher A Potter; Mamta Sattavat; Paul A Garcia; Howard J Rosen; Bruce L Miller; Stephen J DeArmond
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

Review 3.  The role of diffusion tensor imaging in the evaluation of ischemic brain injury - a review.

Authors:  Christopher H Sotak
Journal:  NMR Biomed       Date:  2002 Nov-Dec       Impact factor: 4.044

4.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.

Authors:  Ryuichiro Atarashi; Katsuya Satoh; Kazunori Sano; Takayuki Fuse; Naohiro Yamaguchi; Daisuke Ishibashi; Takehiro Matsubara; Takehiro Nakagaki; Hitoki Yamanaka; Susumu Shirabe; Masahito Yamada; Hidehiro Mizusawa; Tetsuyuki Kitamoto; Genevieve Klug; Amelia McGlade; Steven J Collins; Noriyuki Nishida
Journal:  Nat Med       Date:  2011-01-30       Impact factor: 53.440

5.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

6.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

7.  Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease.

Authors:  Sanjay Mittal; Peter Farmer; Peter Kalina; Peter B Kingsley; John Halperin
Journal:  Arch Neurol       Date:  2002-01

8.  Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.

Authors:  Julie Ann Edgeworth; Michael Farmer; Anita Sicilia; Paul Tavares; Jonathan Beck; Tracy Campbell; Jessica Lowe; Simon Mead; Peter Rudge; John Collinge; Graham S Jackson
Journal:  Lancet       Date:  2011-02-05       Impact factor: 79.321

Review 9.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

10.  Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease.

Authors:  R J Castellani; M Colucci; Z Xie; W Zou; C Li; P Parchi; S Capellari; M Pastore; M H Rahbar; S G Chen; P Gambetti
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

View more
  15 in total

1.  Diagnostic value of diffusion-weighted brain magnetic resonance imaging in patients with sporadic Creutzfeldt-Jakob disease: a systematic review and meta-analysis.

Authors:  Ho Young Park; Minjae Kim; Chong Hyun Suh; Sang Yeong Kim; Woo Hyun Shim; Sang Joon Kim
Journal:  Eur Radiol       Date:  2021-05-12       Impact factor: 5.315

Review 2.  Neurological update: dementia.

Authors:  A J Larner
Journal:  J Neurol       Date:  2014-02-06       Impact factor: 4.849

Review 3.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

4.  Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging.

Authors:  Alberto Bizzi; Riccardo Pascuzzo; Janis Blevins; Marina Grisoli; Raffaele Lodi; Marco E M Moscatelli; Gianmarco Castelli; Mark L Cohen; Lawrence B Schonberger; Aaron Foutz; Jiri G Safar; Brian S Appleby; Pierluigi Gambetti
Journal:  JAMA Neurol       Date:  2020-09-01       Impact factor: 18.302

Review 5.  Therapeutic strategies for identifying small molecules against prion diseases.

Authors:  Elisa Uliassi; Lea Nikolic; Maria Laura Bolognesi; Giuseppe Legname
Journal:  Cell Tissue Res       Date:  2022-01-06       Impact factor: 5.249

6.  Sleep Pathology in Creutzfeldt-Jakob Disease.

Authors:  Peter Kang; Gabriela S de Bruin; Leo H Wang; Beth A Ward; Beau M Ances; Miranda M Lim; Robert C Bucelli
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

Review 7.  Diagnosis and evaluation of a patient with rapidly progressive dementia.

Authors:  Robert C Bucelli; Beau M Ances
Journal:  Mo Med       Date:  2013 Sep-Oct

8.  White matter involvement in sporadic Creutzfeldt-Jakob disease.

Authors:  Eduardo Caverzasi; Maria Luisa Mandelli; Stephen J DeArmond; Christopher P Hess; Paolo Vitali; Nico Papinutto; Abby Oehler; Bruce L Miller; Irina V Lobach; Stefano Bastianello; Michael D Geschwind; Roland G Henry
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

9.  White Matter Integrity Involvement in the Preclinical Stage of Familial Creutzfeldt-Jakob Disease: A Diffusion Tensor Imaging Study.

Authors:  Donglai Jing; Yaojing Chen; Kexin Xie; Yue Cui; Chunlei Cui; Li Liu; Hui Lu; Jing Ye; Ran Gao; Lin Wang; Zhigang Liang; Zhanjun Zhang; Liyong Wu
Journal:  Front Aging Neurosci       Date:  2021-05-19       Impact factor: 5.750

10.  Application of quantitative DTI metrics in sporadic CJD.

Authors:  E Caverzasi; R G Henry; P Vitali; I V Lobach; J Kornak; S Bastianello; S J Dearmond; B L Miller; H J Rosen; M L Mandelli; M D Geschwind
Journal:  Neuroimage Clin       Date:  2014-01-31       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.